Science

Mar 4, 2025, 10:05

Myeloma Paper of the Day, March 4th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: CD8 T cells with a transgenic TCR targeting a peptide derived from BOB1 in context of HLA-B*07:02 + a BCMA-targeting CAR enhances efficacy, but CAR-mediated target recognition may limit TCR-mediated target recognition.”

“CAR-mediated target recognition limits TCR-mediated target recognition of TCR- and CAR-dual-receptor-edited T cells”

Authors: Tassilo Wachsmann, Teuntje Poortvliet, Miranda Meeuwsen, Dennis Remst, Marijke Toes, Anne Wouters, Renate Hagedoorn, Frederik Falkenburg, and Mirjam Heemskerk.

More posts featuring Robert Orlowski.

Anne Wouters cancer Dennis Remst Frederik Falkenburg Marijke Toes Miranda Meeuwsen Mirjam Heemskerk Myeloma Paper of the Day OncoDaily Oncology Renate Hagedoorn Robert Orlowski Tassilo Wachsmann Teuntje Poortvliet

Beyond the Red Carpet: Oscar Winners and Nominees Who Fought Cancer

Oncologist Near Me – Lidia Schapira: A Leader in Cancer Care and Medical Education

CancerWorld welcomes their Co-Editors-in-Chief

Dr. Manette Le Grange joins OncoDaily Editorial Board

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma